Published 1992 | Version v1
Book

Uptake of boronated monoclonal antibodies by melanoma cells visualized by track etch autoradiography and electron energy loss spectroscopy

  • 1. Univ. of Sydney (Australia)
  • 2. Radcliffe infirmary, Oxford (United Kingdom)
  • 3. Australian Nuclear Science and Technology Organisation, Menai (Australia)
  • 4. AEA Technology, Harwell (United Kingdom)

Description

The monoclonal antibody (MAb) NKI-C3 (Netherlands Cancer Institute) is a murine IgG1 known to react with a formalin resistant antigen expressed by more than 95% of human melanomas. In principle, it can be used in the diagnosis of tissue sections for the presence of melanocytes, and with the appropriate level of boron labelling, this antibody could also be used for NCT of melanoma, provided its specificity is not impaired by the labelling process. The present study involves the use of two imaging techniques: first, α-track etch autoradiography to determine the specificity of the MAb after boronation, and second, electron energy loss spectroscopy to obtain information at the subcellular level concerning the localization of the boron label

Additional details

Publishing Information

Publisher
Plenum Press.
Imprint Place
New York, NY (United States)
Imprint Title
Progress in neutron capture therapy for cancer
Imprint Pagination
668 p.
Journal Page Range
p. 335-338.

Conference

Title
4. international symposium on neutron capture therapy for cancer.
Dates
4-7 Dec 1990.
Place
Sydney (Australia).

INIS

Country of Publication
United States
Country of Input or Organization
United States
INIS RN
24015327
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Conference
Descriptors DEI
AUTORADIOGRAPHY; BIOLOGICAL LOCALIZATION; BORON 10; MELANOMAS; MONOCLONAL ANTIBODIES; NEUTRON CAPTURE THERAPY; SPECIFICITY; TUMOR CELLS; UPTAKE
Descriptors DEC
ANIMAL CELLS; ANTIBODIES; BORON ISOTOPES; CARCINOMAS; DISEASES; EPITHELIOMAS; ISOTOPES; LIGHT NUCLEI; MEDICINE; NEOPLASMS; NEUTRON THERAPY; NUCLEI; ODD-ODD NUCLEI; RADIOTHERAPY; STABLE ISOTOPES; THERAPY